Protease-activated receptor-2 stimulates angiogenesis and accelerates hemodynamic recovery in a mouse model of hindlimb ischemia

Anna F. Milia, Maria B. Salis, Tiziana Stacca, Alessandra Pinna, Paolo Madeddu, Marcello Trevisani, Pierangelo Geppetti, Costanza Emanueli

Research output: Contribution to journalArticle

65 Citations (Scopus)

Abstract

Proteinase-activated receptors (PAR-2) are expressed by the cardiovascular system and mediate vasodilation, plasma protein extravasation, and endothelial cell proliferation, all regarded as essential steps for neovascularization. We investigated the angiogenic action of PAR-2 signaling in vivo. The effect of the PAR-2 activating peptide (PAR-2AP, SLIGRL-NH2) was assessed in the absence of ischemia, and the therapeutic potential of PAR-2AP and the PAR-2 agonist trypsin (at 300 and 1.5 nmol IM daily for 21 days, respectively) was also tested in mice subjected to unilateral limb ischemia. PAR-2AP increased capillarity in normoperfused adductor skeletal muscles, whereas neither the vehicle of the PAR2-AP nor the PAR-2 reverse peptide (PAR-2RP, LRGILS-NH2) did produce any effect. In addition, both PAR-2AP and trypsin enhanced reparative angiogenic response to limb ischemia, an effect that was not produced by PAR-2RP or the vehicle of PAR-2 agonists. Potentiation of reparative angiogenesis by PAR-2AP or trypsin resulted in an accelerated hemodynamic recovery and enhanced limb salvage. In conclusions, our study is the first to demonstrate the angiogenic potential of PAR-2 stimulation in vivo. If similar effects occur in humans, PAR-2AP agonists could have some therapeutic potential for the treatment of tissue ischemia.

Original languageEnglish
Pages (from-to)346-352
Number of pages7
JournalCirculation Research
Volume91
Issue number4
DOIs
Publication statusPublished - Aug 23 2002

Fingerprint

PAR-2 Receptor
Hindlimb
Ischemia
Hemodynamics
Trypsin
Extremities
Capillary Action
Limb Salvage
Peptides
Cardiovascular System
Vasodilation
Blood Proteins
Skeletal Muscle
Therapeutics
Endothelial Cells
Cell Proliferation

Keywords

  • Angiogenesis
  • Ischemia
  • Proteinase-activated receptor-2
  • Skeletal muscle

ASJC Scopus subject areas

  • Physiology
  • Cardiology and Cardiovascular Medicine

Cite this

Protease-activated receptor-2 stimulates angiogenesis and accelerates hemodynamic recovery in a mouse model of hindlimb ischemia. / Milia, Anna F.; Salis, Maria B.; Stacca, Tiziana; Pinna, Alessandra; Madeddu, Paolo; Trevisani, Marcello; Geppetti, Pierangelo; Emanueli, Costanza.

In: Circulation Research, Vol. 91, No. 4, 23.08.2002, p. 346-352.

Research output: Contribution to journalArticle

Milia, Anna F. ; Salis, Maria B. ; Stacca, Tiziana ; Pinna, Alessandra ; Madeddu, Paolo ; Trevisani, Marcello ; Geppetti, Pierangelo ; Emanueli, Costanza. / Protease-activated receptor-2 stimulates angiogenesis and accelerates hemodynamic recovery in a mouse model of hindlimb ischemia. In: Circulation Research. 2002 ; Vol. 91, No. 4. pp. 346-352.
@article{75b9dcf6a6b3407b97267fe081b8b5c6,
title = "Protease-activated receptor-2 stimulates angiogenesis and accelerates hemodynamic recovery in a mouse model of hindlimb ischemia",
abstract = "Proteinase-activated receptors (PAR-2) are expressed by the cardiovascular system and mediate vasodilation, plasma protein extravasation, and endothelial cell proliferation, all regarded as essential steps for neovascularization. We investigated the angiogenic action of PAR-2 signaling in vivo. The effect of the PAR-2 activating peptide (PAR-2AP, SLIGRL-NH2) was assessed in the absence of ischemia, and the therapeutic potential of PAR-2AP and the PAR-2 agonist trypsin (at 300 and 1.5 nmol IM daily for 21 days, respectively) was also tested in mice subjected to unilateral limb ischemia. PAR-2AP increased capillarity in normoperfused adductor skeletal muscles, whereas neither the vehicle of the PAR2-AP nor the PAR-2 reverse peptide (PAR-2RP, LRGILS-NH2) did produce any effect. In addition, both PAR-2AP and trypsin enhanced reparative angiogenic response to limb ischemia, an effect that was not produced by PAR-2RP or the vehicle of PAR-2 agonists. Potentiation of reparative angiogenesis by PAR-2AP or trypsin resulted in an accelerated hemodynamic recovery and enhanced limb salvage. In conclusions, our study is the first to demonstrate the angiogenic potential of PAR-2 stimulation in vivo. If similar effects occur in humans, PAR-2AP agonists could have some therapeutic potential for the treatment of tissue ischemia.",
keywords = "Angiogenesis, Ischemia, Proteinase-activated receptor-2, Skeletal muscle",
author = "Milia, {Anna F.} and Salis, {Maria B.} and Tiziana Stacca and Alessandra Pinna and Paolo Madeddu and Marcello Trevisani and Pierangelo Geppetti and Costanza Emanueli",
year = "2002",
month = "8",
day = "23",
doi = "10.1161/01.RES.0000031958.92781.9E",
language = "English",
volume = "91",
pages = "346--352",
journal = "Circulation Research",
issn = "0009-7330",
publisher = "Lippincott Williams and Wilkins",
number = "4",

}

TY - JOUR

T1 - Protease-activated receptor-2 stimulates angiogenesis and accelerates hemodynamic recovery in a mouse model of hindlimb ischemia

AU - Milia, Anna F.

AU - Salis, Maria B.

AU - Stacca, Tiziana

AU - Pinna, Alessandra

AU - Madeddu, Paolo

AU - Trevisani, Marcello

AU - Geppetti, Pierangelo

AU - Emanueli, Costanza

PY - 2002/8/23

Y1 - 2002/8/23

N2 - Proteinase-activated receptors (PAR-2) are expressed by the cardiovascular system and mediate vasodilation, plasma protein extravasation, and endothelial cell proliferation, all regarded as essential steps for neovascularization. We investigated the angiogenic action of PAR-2 signaling in vivo. The effect of the PAR-2 activating peptide (PAR-2AP, SLIGRL-NH2) was assessed in the absence of ischemia, and the therapeutic potential of PAR-2AP and the PAR-2 agonist trypsin (at 300 and 1.5 nmol IM daily for 21 days, respectively) was also tested in mice subjected to unilateral limb ischemia. PAR-2AP increased capillarity in normoperfused adductor skeletal muscles, whereas neither the vehicle of the PAR2-AP nor the PAR-2 reverse peptide (PAR-2RP, LRGILS-NH2) did produce any effect. In addition, both PAR-2AP and trypsin enhanced reparative angiogenic response to limb ischemia, an effect that was not produced by PAR-2RP or the vehicle of PAR-2 agonists. Potentiation of reparative angiogenesis by PAR-2AP or trypsin resulted in an accelerated hemodynamic recovery and enhanced limb salvage. In conclusions, our study is the first to demonstrate the angiogenic potential of PAR-2 stimulation in vivo. If similar effects occur in humans, PAR-2AP agonists could have some therapeutic potential for the treatment of tissue ischemia.

AB - Proteinase-activated receptors (PAR-2) are expressed by the cardiovascular system and mediate vasodilation, plasma protein extravasation, and endothelial cell proliferation, all regarded as essential steps for neovascularization. We investigated the angiogenic action of PAR-2 signaling in vivo. The effect of the PAR-2 activating peptide (PAR-2AP, SLIGRL-NH2) was assessed in the absence of ischemia, and the therapeutic potential of PAR-2AP and the PAR-2 agonist trypsin (at 300 and 1.5 nmol IM daily for 21 days, respectively) was also tested in mice subjected to unilateral limb ischemia. PAR-2AP increased capillarity in normoperfused adductor skeletal muscles, whereas neither the vehicle of the PAR2-AP nor the PAR-2 reverse peptide (PAR-2RP, LRGILS-NH2) did produce any effect. In addition, both PAR-2AP and trypsin enhanced reparative angiogenic response to limb ischemia, an effect that was not produced by PAR-2RP or the vehicle of PAR-2 agonists. Potentiation of reparative angiogenesis by PAR-2AP or trypsin resulted in an accelerated hemodynamic recovery and enhanced limb salvage. In conclusions, our study is the first to demonstrate the angiogenic potential of PAR-2 stimulation in vivo. If similar effects occur in humans, PAR-2AP agonists could have some therapeutic potential for the treatment of tissue ischemia.

KW - Angiogenesis

KW - Ischemia

KW - Proteinase-activated receptor-2

KW - Skeletal muscle

UR - http://www.scopus.com/inward/record.url?scp=0037163104&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037163104&partnerID=8YFLogxK

U2 - 10.1161/01.RES.0000031958.92781.9E

DO - 10.1161/01.RES.0000031958.92781.9E

M3 - Article

C2 - 12193468

AN - SCOPUS:0037163104

VL - 91

SP - 346

EP - 352

JO - Circulation Research

JF - Circulation Research

SN - 0009-7330

IS - 4

ER -